4|1|Public
50|$|<b>Imipraminoxide</b> {{has been}} {{said to be a}} prodrug of imipramine.|$|E
50|$|<b>Imipraminoxide</b> {{is both an}} {{analogue}} and a metabolite of imipramine, and {{has similar}} effects. However, in clinical trials, <b>imipraminoxide</b> {{was found to have}} a faster onset of action, slightly higher efficacy, and fewer and less marked side effects, including diminished orthostatic hypotension and anticholinergic effects like dry mouth, sweating, dizziness, and fatigue.|$|E
50|$|Many {{tricyclic}} antidepressants (TCAs) including clomipramine, desipramine, imipramine, <b>imipraminoxide,</b> lofepramine, metapramine, opipramol, quinupramine, and trimipramine contain saturated dibenzazepine moieties {{in their}} chemical structures.|$|E
50|$|<b>Imipraminoxides</b> {{pharmacology}} has {{not been}} well elucidated, but based on its very close relationship with imipramine, it likely acts as a serotonin and norepinephrine reuptake inhibitor and serotonin, adrenenaline, histamine, and muscarinic acetylcholine receptor antagonist, though with weaker antiadrenergic and anticholinergic actions.|$|R
50|$|<b>Imipraminoxide</b> (brand names Imiprex, Elepsin), or {{imipramine}} N-oxide, is a {{tricyclic antidepressant}} (TCA) that {{was introduced in}} Europe in the 1960s {{for the treatment of}} depression.|$|E

